Stress News and Research

RSS

AstraZeneca grants $2.5 million to 14 U.S.-based organizations to improve cardiovascular health

The AstraZeneca HealthCare Foundation today announced grants totaling more than $2.5 million to 14 U.S.-based nonprofit organizations from Maine to California dedicated to improving cardiovascular health in local communities.

8 Mar 2011

Article sheds new light on neural mechanisms for flashbacks

Flashbacks are an elusive phenomenon, but an article published in the current issue of Psychotherapy and Psychosomatics sheds some new light on potential mechanisms in an healthy man with an history of near drawing.

7 Mar 2011

Inovio initiates VGX-3100 Phase II trial in patients with cervical cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus.

7 Mar 2011

Core Performance uses IBM software to help consumers reach their fitness goals

IBM today announced that a leading provider of corporate fitness services is using business rules software to customize individual workouts to help consumers reach their fitness goals in the New Year.

5 Mar 2011

GW Health Policy Researchers play a major role in AJPM supplement

GW Health Policy Researchers, led by Wilhelmine Miller, Ph.D., associate research professor in the School of Public Health and Health Services, Department of Health Policy, played a major role in the supplement of the American Journal of Preventive Medicine, funded by the Robert Wood Johnson Foundation.

5 Mar 2011

Aflac receives two Communitas Awards for excellence in community service, corporate social responsibility

Aflac, the company that pays cash benefits fast when you are sick or hurt, today announced that it has been awarded two Communitas Awards for excellence in community service and corporate social responsibility. Winners are recognized for specific programs involving volunteerism, philanthropy, or ethical and sustainable business practices.

5 Mar 2011

Family-assisted exercise therapy improves function, recovery after stroke: Study

Your family's involvement in your exercise therapy could significantly improve your function and recovery after stroke, according to a study in the March print issue of Stroke: Journal of the American Heart Association.

5 Mar 2011

Scientist discovers new mechanism for regulation of gene expression

Dr. David Levin, Professor of Molecular & Cell Biology at Boston University Henry M. Goldman School of Dental Medicine and Professor of Microbiology at Boston University School of Medicine discovered recently a novel, evolutionarily conserved mechanism for the regulation of gene expression.

4 Mar 2011

Study: Job satisfaction affects quality of sleep

The employed and self-employed enjoy much better sleep than those out of work, according to Understanding Society, the world's largest longitudinal household study.

4 Mar 2011

Study finds variation in drinking patterns among men, women depending on neighborhood type

Men living in low-income neighbourhoods consume more than three times as many alcoholic drinks each week compared to women in these neighbourhoods, according to a study led by St. Michael's researcher Flora Matheson.

4 Mar 2011

Researchers investigate why immune system is blunted after spinal cord injury

Mobility is a challenge for spinal cord injured patients. Infection is another. Adam Thrasher, assistant professor of health and human performance, says infection is the leading cause of death for people living with spinal cord injuries for two years or more.

4 Mar 2011

How cancer impacts patients and their partners

Katarina Sjövall has studied partners of individuals with colorectal cancer, lung cancer, breast cancer or prostate cancer. The study shows that the number of diagnosed diseases among partners increased by 25 per cent after the cancer diagnosis.

4 Mar 2011

New, inexpensive method to accurately differentiate between benign and malignant breast tumors

Recent research by doctoral student Sevan Goenezen holds the promise of becoming a powerful new weapon in the fight against breast cancer. His complex computational research has led to a fast, inexpensive new method for using ultrasound and advanced algorithms to differentiate between benign and malignant tumors with a high degree of accuracy.

4 Mar 2011

Novel study deepens understanding of how chromosome replication works

A novel study from the Swedish medical university Karolinska Institutet has deepened the understanding of how chromosome replication, one of life's most fundamental processes, works.

3 Mar 2011

New research: Weight discrimination may impact physical health

The discrimination that obese people feel, whether it is poor service at a restaurant or being treated differently in the workplace, may have a direct impact on their physical health, according to new research from Purdue University.

3 Mar 2011

ASU receives W. M. Keck $1 million grant to build next-generation 3D imaging microscope

The W. M. Keck Foundation has awarded Arizona State University a $1 million grant to the team of scientists led by Deirdre Meldrum, Ph.D., at the Biodesign Institute.

2 Mar 2011

Reliv fourth-quarter net sales decrease to $18.5 million

Reliv International, Inc. a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth-quarter and full-year of 2010.

2 Mar 2011

New colon cancer screening campaign initiative in New York City

In honor of National Colon Cancer Awareness Month, Katie Couric, the New York City Department of Health and Mental Hygiene, WCBS-TV and The Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian Hospital announced the launch of the "Make That Call" for colon cancer screening campaign.

2 Mar 2011

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Neuralstem, Inc. announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single dose.

2 Mar 2011

Study: Happy people tend to live longer and experience better health

A review of more than 160 studies of human and animal subjects has found "clear and compelling evidence" that - all else being equal - happy people tend to live longer and experience better health than their unhappy peers.

1 Mar 2011